JWM
ACTU

JPL Wealth Management’s Actuate Therapeutics ACTU Stock Holding History

JPL Wealth Management’s Portfolio ACTU Stock Details ACTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2 Buy
+1
New +$2 ﹤0.01% 1875

Other funds holding ACTU

BCM
BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.87B AUM 24.49% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $304M AUM 15.15% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ADEF
ABS Direct Equity Fund Stamford, Connecticut $159M AUM 34.17% 1-Year Est. Return

JPL Wealth Management's ACTU Position: Q2 2026 in Review

JPL Wealth Management opened a new position in Actuate Therapeutics (ACTU) in Q2 2026: 1 share worth $2. The stake represents ﹤0.01% of the portfolio and ranks #1875 among its holdings.

64 funds tracked by Wall St. Rank hold ACTU as of Q2 2026.

  • JPL Wealth Management held 1 share of Actuate Therapeutics worth $2 as of Q2 2026.
  • Actuate Therapeutics was a new JPL Wealth Management position in Q2 2026.
  • Actuate Therapeutics made up ﹤0.01% of JPL Wealth Management's portfolio in Q2 2026, its #1875 holding.
  • 64 funds tracked by Wall St. Rank held Actuate Therapeutics as of Q2 2026.

Based on JPL Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.